Canvas Wealth Advisors, LLC Biogen Inc. Transaction History

Canvas Wealth Advisors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 28, 2022	BUY	$194.69 - $268.46 $148,353 - $204,566	762 New	762 $214,000
Q1 2022 May 09, 2022	SELL	$193.77 - $244.14 $164,704 - $207,519	-850 Closed	0 $0
Q4 2021 Jan 19, 2022	BUY	$223.92 - $287.77 $16,346 - $21,007	73 Added 9.4%	850 $204,000
Q3 2021 Oct 15, 2021	BUY	$282.99 - $369.05 $2,263 - $2,952	8 Added 1.04%	777 $220,000
Q2 2021 Aug 02, 2021	BUY	$259.0 - $414.71 $199,171 - $318,911	769 New	769 $266,000

992

130M

1.12M

1.43M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $20.5B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Canvas Wealth Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Canvas Wealth Advisors, LLC with notifications on news.